Safety study of Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH) in ADHD
This study is completed in the United States. It is testing Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH) for ADHD.
ADHD, Attention Deficit/Hyperactivity DisorderDrugFrom 4 Years to 5 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH) may be useful for children experiencing ADHD.
What would participation involve?
Participants may receive Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), attend study visits with the research team. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for children with ADHD. Because it involves minors, a parent or guardian may need to be involved.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: June 2, 2023
Recruitment status
Completed
Enrollment listed in the registry
123
Sponsor
Corium, Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 4 Years to 5 Years
Official registry ID
NCT05721235
Official title
A Multicenter, Dose-Optimized, Open-Label, Safety/Tolerability and Pharmacokinetic Study With Azstarys® in Children 4 and 5 Years of Age With Attention-Deficit/Hyperactivity Disorder
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 20 sites
Preferred Research Partners (PRP)
Little Rock, Arkansas
Site status: Not listed — confirm with the team
Advanced Research Center (ARC)
Anaheim, California
Site status: Not listed — confirm with the team
IMMUNOe International Research Center
Centennial, Colorado
Site status: Not listed — confirm with the team
Clinical Neuroscience Solutions - Orlando
Jacksonville, Florida
Site status: Not listed — confirm with the team
Accel Research Sites - Lakeland
Lakeland, Florida
Site status: Not listed — confirm with the team
Accel Research Sites - Maitland
Maitland, Florida
Site status: Not listed — confirm with the team
South Florida Research Phase I-IV INC
Miami Springs, Florida
Site status: Not listed — confirm with the team
CNS Healthcare - Orlando
Orlando, Florida
Site status: Not listed — confirm with the team
iResearch Atlanta
Decatur, Georgia
Site status: Not listed — confirm with the team
CenExel iResearch, LLC
Savannah, Georgia
Site status: Not listed — confirm with the team
Sky Clinical Research Network Group P.C.
Union City, Georgia
Site status: Not listed — confirm with the team
DelRicht Research - Touro Medical Center
New Orleans, Louisiana
Site status: Not listed — confirm with the team
St Charles Psychiatric Associates & Midwest Research Group
Saint Charles, Missouri
Site status: Not listed — confirm with the team
Boeson Research
Missoula, Montana
Site status: Not listed — confirm with the team
Alivation Research, LLC
Lincoln, Nebraska
Site status: Not listed — confirm with the team
Center For Psychiatry and Behavioral Medicine Inc
Las Vegas, Nevada
Site status: Not listed — confirm with the team
Clinical Neuroscience Solution, Inc
Memphis, Tennessee
Site status: Not listed — confirm with the team
Houston Clinical Trials
Bellaire, Texas
Site status: Not listed — confirm with the team
AIM Trials
Plano, Texas
Site status: Not listed — confirm with the team
Flourish Research
San Antonio, Texas
Site status: Not listed — confirm with the team
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT05721235. We help you review the study, but cannot decide medical eligibility.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH). Phase 4 studies usually happen after treatment approval, to monitor real-world use.
Who might this study be for?
This study may concern people with adhd; age range: From 4 Years to 5 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Corium, Inc., which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
